ANAB Anaptysbio Inc

Price (delayed)

$23.24

Market cap

$636M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.73

Enterprise value

$385.48M

Sector: Healthcare
Industry: Biotechnology

Highlights

ANAB's debt has plunged by 100% YoY
The net income has soared by 80% YoY and by 73% QoQ
Anaptysbio's equity has increased by 10% from the previous quarter but it has decreased by 2% YoY

Key stats

What are the main financial stats of ANAB
Market
Shares outstanding
27.37M
Market cap
$636M
Enterprise value
$385.48M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.6
Price to sales (P/S)
8.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.14
Earnings
Revenue
$75M
EBIT
-$19.93M
EBITDA
-$19.37M
Free cash flow
-$14.73M
Per share
EPS
-$0.73
Free cash flow per share
-$0.54
Book value per share
$14.51
Revenue per share
$2.75
TBVPS
$15.26
Balance sheet
Total assets
$416.55M
Total liabilities
$19.82M
Debt
$0
Equity
$396.73M
Working capital
$376.74M
Liquidity
Debt to equity
0
Current ratio
20.01
Quick ratio
19.86
Net debt/EBITDA
12.93
Margins
EBITDA margin
-25.8%
Gross margin
100%
Net margin
-26.6%
Operating margin
-31.8%
Efficiency
Return on assets
-4.9%
Return on equity
-5.2%
Return on invested capital
-11.5%
Return on capital employed
-5%
Return on sales
-26.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANAB stock price

How has the Anaptysbio stock price performed over time
Intraday
1.84%
1 week
7%
1 month
10.98%
1 year
48.5%
YTD
8.09%
QTD
7.84%

Financial performance

How have Anaptysbio's revenue and profit performed over time
Revenue
$75M
Gross profit
$75M
Operating income
-$23.88M
Net income
-$19.93M
Gross margin
100%
Net margin
-26.6%
The company's operating margin has surged by 98% YoY and by 93% QoQ
ANAB's net margin has soared by 98% YoY and by 94% from the previous quarter
The net income has soared by 80% YoY and by 73% QoQ
ANAB's operating income has surged by 78% year-on-year and by 70% since the previous quarter

Growth

What is Anaptysbio's growth rate over time

Valuation

What is Anaptysbio stock price valuation
P/E
N/A
P/B
1.6
P/S
8.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.14
ANAB's EPS has surged by 80% year-on-year and by 73% since the previous quarter
ANAB's P/B is 60% lower than its 5-year quarterly average of 3.9 but 21% higher than its last 4 quarters average of 1.3
Anaptysbio's equity has increased by 10% from the previous quarter but it has decreased by 2% YoY
The stock's price to sales (P/S) is 95% less than its 5-year quarterly average of 165.5 and 59% less than its last 4 quarters average of 20.2

Efficiency

How efficient is Anaptysbio business performance
ANAB's return on sales has surged by 98% year-on-year and by 93% since the previous quarter
The ROA has soared by 77% YoY and by 73% QoQ
Anaptysbio's return on equity has surged by 77% YoY and by 73% QoQ
The return on invested capital has surged by 69% since the previous quarter and by 66% year-on-year

Dividends

What is ANAB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANAB.

Financial health

How did Anaptysbio financials performed over time
The company's quick ratio has surged by 57% YoY and by 44% QoQ
The current ratio has surged by 56% year-on-year and by 42% since the previous quarter
ANAB's debt is 100% less than its equity
ANAB's debt has plunged by 100% YoY
Anaptysbio's equity has increased by 10% from the previous quarter but it has decreased by 2% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.